roche
Restructuring costs reduce Roche profits
Global restructuring costs ate into profits as Swiss drugs giant Roche on Wednesday recorded a 16 percent drop in net income to 9.5 billion francs ($10.5 billion) for 2014.
Global restructuring costs ate into profits as Swiss drugs giant Roche on Wednesday recorded a 16 percent drop in net income to 9.5 billion francs ($10.5 billion) for 2014.